clinical trial · NCT00861042
An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy
UCB Pharma·phase2·completed·n = 69
Painful Diabetic NeuropathySPM927/Lacosamide
brief summary
The primary objective of the trial is to assess the tolerability and safety of long-term SPM 927 administration in subjects with diabetic neuropathy.
started
Apr 1, 2002
primary completion
Dec 1, 2004
completion
Mar 1, 2005
last updated
Jan 29, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol